Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical …
Over the last 12 months, insiders at Avalon GloboCare Corp. have bought $0 and sold $0 worth of Avalon GloboCare Corp. stock.
On average, over the past 5 years, insiders at Avalon GloboCare Corp. have bought $1,000,000 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 645,161 shares for transaction amount of $1,000,000 was made by Lu Wenzhao () on 2020‑04‑01.
2020-04-01 | 645,161 32.639% | $1.55 | $1,000,000 | +7.56% | ||||
2019-06-07 | 15,000 0.9008% | $1.84 | $27,600 | -11.56% | ||||
2019-06-06 | 21,000 1.3914% | $2.03 | $42,630 | -7.59% | ||||
2019-04-18 | 2M 65.2781% | $1.00 | $2M | -60.88% | ||||
2017-12-15 | director | 1,000 0.0804% | $2.46 | $2,462 | +44.44% | |||
2017-11-20 | director | 5,300 0.3309% | $1.91 | $10,138 | +30.00% | |||
2017-04-20 | Sale | director | 5M 81.5976% | $0.50 | $2.5M | +166.67% | ||
2017-04-01 | director | 211,415 10.9502% | $1.59 | $335,490 | +34.23% |
Lu Wenzhao | 2645161 241.7394% | $4.10 | 4 | 1 | +7.56% | |
Sukel Steven Philip | director | 217615 19.8877% | $4.10 | 3 | 0 |